Publications

Select keywords to filter the posts for matching content:

Keywords
Topics
  • Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes.
    T.Biester, B. Aschemeier, M. Fath, M. Frey, M. F. Scheerer, O. Kordonouri, T. Danne
    PMID: 28417527 Show Details link to full text
    Study

    DAPA IIT179

    Year

    2017

    Keywords
    • dapagliflozin
    • type 1 diabetes
  • The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
    B. A. S. Jaeger BAS, J. Neugebauer, U. Andergassen, C. Melcher, F. Schochter, D. Mouarrawy, G. Ziemendorff, M. Clemens, V. E. Abel, G. Heinrich, K. Schueller, A. Schneeweiss, P. Fasching, M. W. Beckmann, C. Scholz, T. W. P. Friedl, K. Friese, K. Pantel, T. Fehm, W. Janni, B. Rack
    PMID: 28586395 Show Details link to full text
    Study

    SUCCESS B

    Year

    2017

    Keywords
    • HER2
    • breast cancer
    • oncology
  • Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' study
    R. D. Hofheinz, C. Lange, T. Ecke, S. Kloss, B. Linsse, C. Windemuth-Kieselbach, P. Hammerer, S. E. Al-Batran
    PMID: 27618249 Show Details link to full text
    Study

    QoLiTime

    Year

    2017

    Keywords
    • cabazitaxel
    • mCRPC
    • QoL
    • oncology
  • PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives
    J. Sehouli, E. I. Braicu, R. Chekerov
    PMID: 26941449 Show Details link to full text
    Study

    Year

    2016

    Keywords
    • PARP inhibitors
    • ovarian cancer
    • oncology
  • Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
    L. Zimmer, J. Vaubel, P. Mohr, A. Hauschild, J. Utikal, J. Simon, C. Garbe, R. Herbst, A. Enk, E. Kämpgen, E. Livingstone, L. Bluhm, R. Rompel, K. G. Griewank, M. Fluck, B. Schilling, D. Schadendorf
    PMID: 25761109 Show Details link to full text
    Study

    Multibasket/DeCOG

    Year

    2015

    Keywords
    • uveal melanoma
    • ipilimumab
    • oncology
  • Therapieinnovation: Der PARP Inhibitor Olaparib, Diagnostik und Therapie
    J. Pfisterer, F. Hilpert, A. du Bois
    PMID: Show Details link to full text
    Study

    Year

    2015

    Keywords
    • ovarian cancer
    • Olaparib
    • PARP inhibitors
    • oncology
  • Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
    S. Kasper, J. Meiler, H. Knipp, T. Höhler, P. Reimer, T. Steinmetz, W. Berger, G. Linden, H. Reis, P. Markus, A. Paul, A. Dechêne, B. Schumacher, K. Kostbade, I. Virchow, S. Ting, K. Worm, K. W. Schmid, T. Herold, M. Wiesweg, M. Schuler, T.Trarbach
    PMID: 26637909 Show Details link to full text
    Study

    CEBIFOX

    Year

    2015

    Keywords
    • BRAF mutation
    • metastatic colorectal cancer
    • RAS mutation
    • cetuximab
    • oncology
  • Treosulfan in the Treatment of Advanced Ovarian Cancer - Results of a German Multicenter Non-interventional Study
    R. Chekerov, G. Kaltenecker, D. Reichert, T. Göhler, P. Klare, G. Oskay-Özcelik, U. Sauer, A. Wischnik, U. Vehling-Kaiser, M. Becker, U. Hutzschenreuter, A. Ammon, E. Heidrich-Lorsbach, J. Sehouli
    PMID: 26637909 Show Details link to full text
    Study

    Year

    2015

    Keywords
    • Treosulfan
    • ovarian cancer
    • oncology
  • The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).
    S. E. Al-Batran, W. Hozaeel, F. K. Tauchert, R. D. Hofheinz, A. Hinke, C. Windemuth-Kieselbach, A. Hübner, M. Burmester, M. Koenigsmann, J. Wiegand, G. Zur Hause, B. Linsse, R. Kuhl, C. Pauligk
    PMID: 25755108 Show Details link to full text
    Study

    QoliTax

    Year

    2015

    Keywords
    • docetaxel
    • metastatic colorectal cancer
    • QoL
    • oncology
    • HRQoL
  • The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer
    B. Rack, U. Andergassen, J. Neugebauer, J. Salmen, P. Hepp, H. Sommer, W. Lichtenegger, K. Friese, M. W. Beckmann, D. Hauner, H. Hauner, W. Janni
    PMID: 21494405 Show Details link to full text
    Study

    SUCCESS C

    Year

    2010

    Keywords
    • breast cancer
    • oncology
Follow:
Seite: 4/5